Published in Philos Trans R Soc Lond B Biol Sci on October 22, 1970
Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev (2003) 6.67
Biology of Naegleria spp. Microbiol Rev (1988) 2.06
Evaluation of the indirect fluorescent-antibody technique for identification of Naegleria species. Appl Microbiol (1974) 1.59
Comparative antigenic analysis of pathogenic and free-living Naegleria species by the gel diffusion and immunoelectrophoresis techniques. Infect Immun (1975) 1.16
Mitochondrial DNA restriction fragment length polymorphism (RFLP) and 18S small-subunit ribosomal DNA PCR-RFLP analyses of Acanthamoeba isolated from contact lens storage cases of residents in southwestern Korea. J Clin Microbiol (2002) 0.98
Limax amoebae in public swimming pools of albany, schenectady, and rensselaer counties, new york: their concentration, correlations, and significance. Appl Environ Microbiol (1977) 0.95
Genetic analyses of Acanthamoeba isolates from contact lens storage cases of students in Seoul, Korea. Korean J Parasitol (2001) 0.93
Immunohistochemical characterization of the initial stages of Naegleria fowleri meningoencephalitis in mice. Parasitol Res (2004) 0.90
Transformation of trophic Hartmannella culbertsoni into viable cysts of cyclic 3',5'-adenosine monophosphate. J Cell Biol (1972) 0.87
A riboprinting scheme for identification of unknown Acanthamoeba isolates at species level. Korean J Parasitol (2002) 0.86
The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol (1970) 5.24
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med (1995) 3.56
A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol (1970) 2.78
Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med (1994) 2.68
Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol (1995) 2.31
New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis (1980) 1.95
The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J Biol Chem (2001) 1.82
Abscisic Acid localization and metabolism in barley aleurone layers. Plant Physiol (1979) 1.71
Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation (1978) 1.68
Plasma propranolol concentration in patients with angina and acute myocardial infarction. Clin Exp Pharmacol Physiol (1976) 1.68
Effects of intravenous verapamil on hemodynamics in patients with heart disease. Am Heart J (1977) 1.63
Effects of amiodarone on thyroid function in patients with ischaemic heart disease. Br Heart J (1975) 1.63
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation (2000) 1.63
Cytologic findings in aspirated hydatid fluid. Acta Cytol (1989) 1.58
Amiodarone and thyroid function. Prog Cardiovasc Dis (1989) 1.55
Review of wheat improvement for waterlogging tolerance in Australia and India: the importance of anaerobiosis and element toxicities associated with different soils. Ann Bot (2008) 1.53
Comparative mechanisms of action of antiarrhythmic drugs. Am Heart J (1974) 1.52
Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. Am J Cardiol (1999) 1.49
Verapamil: a review of its pharmacological properties and therapeutic use. Drugs (1978) 1.47
Non-Q-wave myocardial infarction-current status. J Assoc Physicians India (1988) 1.40
A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function. Cardiovasc Res (1972) 1.36
Hydrolysis of 11-cis- and all-trans-retinyl palmitate by homogenates of human retinal epithelial cells. J Biol Chem (1987) 1.34
Effects of verapamil on infarct size following experimental coronary occlusion. Cardiovasc Res (1975) 1.32
Effect of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit atrial and ventricular muscle. Circ Res (1971) 1.29
Therapeutic implications of slow-channel blockade in cardiocirculatory disorders. Circulation (1980) 1.26
Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone. Am Heart J (1981) 1.25
Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro. Infect Immun (2000) 1.25
Noninvasive identification of a high risk subset of patients with acute inferior myocardial infarction. Am J Cardiol (1980) 1.24
Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias. Pharmacol Rev (1978) 1.23
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab (1981) 1.22
Effects of cardioselective beta adrenoceptor blockade on specific airways resistance in normal subjects and in patients with bronchial asthma. Clin Pharmacol Ther (1976) 1.22
Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations. Am Heart J (1985) 1.22
Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J Am Coll Cardiol (1999) 1.21
Failure of ST segment elevation to predict severity of acute myocardial infarction. Br Heart J (1976) 1.21
Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone. Circulation (1999) 1.20
Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. J Am Coll Cardiol (1986) 1.20
The frequency and prognostic significance of electrocardiographic abnormalities in clinically normal individuals. Prog Cardiovasc Dis (1981) 1.19
The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs. Circulation (1979) 1.17
Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer. Cardiovasc Res (1973) 1.17
Mechanism of rest and nocturnal angina: observations during continuous hemodynamic and electrocardiographic monitoring. Circulation (1979) 1.16
A longitudinal study of the growth in height of boys and girls of West Bengal (India) aged six months of 20 years. Ann Hum Biol (1981) 1.16
Early effects of gibberellic acid on barley aleurone layers. Biochem Biophys Res Commun (1968) 1.15
Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol (1987) 1.14
Amiodarone: historical development and pharmacologic profile. Am Heart J (1983) 1.12
Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. J Hypertens (1992) 1.12
Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations. Am Heart J (1984) 1.11
Local anaesthetic and anti-arrhythmic actions of alprenolol relative to its effect on intracellular potentials and other properties of isolated cardiac muscle. Br J Pharmacol (1970) 1.10
Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med (2000) 1.09
The effects of aging on N-methyl-D-aspartate receptor subunits in the synaptic membrane and relationships to long-term spatial memory. Neuroscience (2009) 1.08
Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. Circulation (1982) 1.05
Left ventricular ejection fraction determined by radionuclide ventriculography in early stages of first transmural myocardial infarction. Relation to short-term prognosis. Am J Cardiol (1980) 1.05
Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias. Drugs (1979) 1.05
Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications. J Cardiovasc Electrophysiol (1995) 1.04
Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J Cardiol (1981) 1.04
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs (1974) 1.02
Amiodarone in refractory life-threatening ventricular arrhythmias. Ann Intern Med (1983) 1.02
QTLs associated with root traits increase yield in upland rice when transferred through marker-assisted selection. Theor Appl Genet (2012) 1.01
Pharmacological basis for the therapeutic applications of slow-channel blocking drugs. Angiology (1982) 1.00
A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patients. HIV Med (2006) 0.99
Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias. Circulation (1985) 0.98
When is QT prolongation antiarrhythmic and when is it proarrhythmic? Am J Cardiol (1989) 0.97
Calcium antagonists. Clinical use in the treatment of arrhythmias. Drugs (1983) 0.97
The mechanism of action of calcium antagonists relative to their clinical applications. Br J Clin Pharmacol (1986) 0.96
Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease. Am Heart J (1985) 0.96
Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during the life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites. Mol Biochem Parasitol (1995) 0.95
Changes in myocardial blood flow and S-T segment elevation following coronary artery occlusion in dogs. Circ Res (1975) 0.94
The primary structure of bovine cellular retinoic acid-binding protein. J Biol Chem (1985) 0.94
Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials. Clin Exp Pharmacol Physiol (1976) 0.94
Synthesis of a ubiquitously present new HSP60 family protein is enhanced by heat shock only in the Malpighian tubules of Drosophila. Experientia (1996) 0.92
Effects of amiodarone and its metabolite, desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle. J Cardiovasc Pharmacol (1986) 0.92
Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues. Antivir Chem Chemother (2001) 0.92
Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications. J Am Coll Cardiol (1984) 0.92
Restoration of virulence to rat of axenically grown Entamoeba histolytica by cholesterol and hamster liver passage. Ann Trop Med Parasitol (1976) 0.91
Phospholipid metabolism of cultured Trichomonas vaginalis and Tritrichomonas foetus. Mol Biochem Parasitol (1991) 0.91
Second-generation calcium antagonists: search for greater selectivity and versatility. Am J Cardiol (1985) 0.91
Effects of amiodarone, sematilide, and sotalol on QT dispersion. Am J Cardiol (1994) 0.91
Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. Am Heart J (1975) 0.91
Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions. Am J Cardiol (1999) 0.90
Free fatty acids of human meconium. Biol Neonate (1986) 0.90
Editors' roundtable: Current formulas for P & T Committee success (Part 1). Hosp Formul (1987) 0.90
Special article. The role of beta-adrenergic blockade in myocardial infarction. Prog Cardiovasc Dis (1974) 0.90
Synthesis and biological activity of isodithiobiurets, dithiobiurets, and dithiazoles. Pharm Res (1987) 0.90
Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Circulation (1996) 0.90
Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery. Angiology (1998) 0.90
A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors. Eur J Pharmacol (1975) 0.90
Biosynthesis of the novel fatty acid, 17-methyl-cis-9,10-methyleneoctadecanoic acid, by the parasitic protozoan, Herpetomonas megaseliae. Lipids (1983) 0.89
Behaviour genetics of Drosophila: non-sexual behaviour. J Genet (2005) 0.89
Amiodarone and post-MI patients. Circulation (1993) 0.89
Electrophysiologic and hemodynamic effects of slow-channel blocking drugs. Prog Cardiovasc Dis (1982) 0.89
Ketanserin and QTc prolongation. Eur Heart J (1987) 0.89
Effects of flecainide on ventricular function: clinical and experimental correlations. Am J Cardiol (1984) 0.88
Mandibular invasion in oral squamous cell carcinoma: investigation by clinical examination and orthopantomogram. Int J Oral Maxillofac Surg (2004) 0.88
Circadian variation in occurrence of transient overt and silent myocardial ischemia in chronic stable angina and comparison with Prinzmetal angina in men. Am J Cardiol (1987) 0.88
Editors' roundtable: current formulas for P & T Committee success. (Part 2). Hosp Formul (1987) 0.88
Circadian rhythmicity of rate-normalized QT interval in hypothyroidism and its significance for development of class III antiarrhythmic agents. Am J Cardiol (1990) 0.88
Evaluation of MK-870: a new potassium-sparing diuretic. Br Med J (1967) 0.88
Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction. Br Heart J (1977) 0.88
Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs. J Clin Invest (1976) 0.88